Ranitidine Use and Incident Cancer in a Multinational Cohort

IMPORTANCE: Ranitidine, the most widely used histamine-2 receptor antagonist (H(2)RA), was withdrawn because of N-nitrosodimethylamine impurity in 2020. Given the worldwide exposure to this drug, the potential risk of cancer development associated with the intake of known carcinogens is an important...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Seng Chan, Seo, Seung In, Falconer, Thomas, Yanover, Chen, Duarte-Salles, Talita, Seager, Sarah, Posada, Jose D., Shah, Nigam H., Nguyen, Phung-Anh, Kim, Yeesuk, Hsu, Jason C., Van Zandt, Mui, Hsu, Min-Huei, Lee, Hang Lak, Ko, Heejoo, Shin, Woon Geon, Pratt, Nicole, Park, Rae Woong, Reich, Christin G., Suchard, Marc A., Hripcsak, George, Park, Chan Hyuk, Prieto-Alhambra, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509724/
https://www.ncbi.nlm.nih.gov/pubmed/37725377
http://dx.doi.org/10.1001/jamanetworkopen.2023.33495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509724/
https://www.ncbi.nlm.nih.gov/pubmed/37725377
http://dx.doi.org/10.1001/jamanetworkopen.2023.33495

Ejemplares similares